|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Markman M: Current standards of care for
chemotherapy of optimally cytoreduced advanced epithelial ovarian
cancer. Gynecol Oncol. 131:241–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H, Zhong A, Sun J, Chen M, Xie S,
Zheng H, Wang Y, Yu Y, Guo L and Lu R: COPS5 inhibition arrests the
proliferation and growth of serous ovarian cancer cells via the
elevation of p27 level. Biochem Biophys Res Commun. 493:85–93.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coscia F, Lengyel E, Duraiswamy J,
Ashcroft B, Bassani-Sternberg M, Wierer M, Johnson A, Wroblewski K,
Montag A, Yamada SD, et al: Multi-level proteomics identifies CT45
as a chemosensitivity mediator and immunotherapy target in ovarian
cancer. Cell. 175:159–170.e16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gentric G, Kieffer Y, Mieulet V, Goundiam
O, Bonneau C, Nemati F, Hurbain I, Raposo G, Popova T, Stern MH, et
al: PML-Regulated mitochondrial metabolism enhances
chemosensitivity in human ovarian cancers. Cell Metab.
29:156–173.e10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Macintyre G, Goranova TE, De Silva D,
Ennis D, Piskorz AM, Eldridge M, Sie D, Lewsley LA, Hanif A, Wilson
C, et al: Copy number signatures and mutational processes in
ovarian carcinoma. Nat Genet. 50:1262–1270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schumacker PT: Reactive oxygen species in
cancer cells: Live by the sword, die by the sword. Cancer Cell.
10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szatrowski TP and Nathan CF: Production of
large amounts of hydrogen peroxide by human tumor cells. Cancer
Res. 51:794–798. 1991.PubMed/NCBI
|
|
9
|
Zou Z, Chang H, Li H and Wang S: Induction
of reactive oxygen species: An emerging approach for cancer
therapy. Apoptosis. 22:1321–1335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pluchino LA, Choudhary S and Wang HC:
Reactive oxygen species-mediated synergistic and preferential
induction of cell death and reduction of clonogenic resistance in
breast cancer cells by combined cisplatin and FK228. Cancer Lett.
381:124–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao S, Xia M, Mao Y, Zhang Q, Donkor PO,
Qiu F and Kang N: Combined oridonin with cetuximab treatment shows
synergistic anticancer effects on laryngeal squamous cell
carcinoma: Involvement of inhibition of EGFR and activation of
reactive oxygen species-mediated JNK pathway. Int J Oncol.
49:2075–2087. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshida H, Matsui T, Yamamoto A, Okada T
and Mori K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in
response to ER stress to produce a highly active transcription
factor. Cell. 107:881–891. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reimold AM, Iwakoshi NN, Manis J,
Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D,
Grusby MJ, Alt F and Glimcher LH: Plasma cell differentiation
requires the transcription factor XBP-1. Nature. 412:300–307. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clauss IM, Gravallese EM, Darling JM,
Shapiro F, Glimcher MJ and Glimcher LH: In situ hybridization
studies suggest a role for the basic region-leucine zipper protein
hXBP-1 in exocrine gland and skeletal development during mouse
embryogenesis. Dev Dyn. 197:146–156. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Romero-Ramirez L, Cao H, Nelson D, Hammond
E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, et
al: XBP1 is essential for survival under hypoxic conditions and is
required for tumor growth. Cancer Res. 64:5943–5947. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Iliopoulos D, Zhang Q, Tang Q,
Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, et
al: XBP1 promotes triple-negative breast cancer by controlling the
HIF1α pathway. Nature. 508:103–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Chen X, Gao Y, Wu J, Zeng F and Song
F: XBP1 induces snail expression to promote
epithelial-to-mesenchymal transition and invasion of breast cancer
cells. Cell Signal. 27:82–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gomez BP, Riggins RB, Shajahan AN, Klimach
U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M and Clarke R: Human
X-box binding protein-1 confers both estrogen independence and
antiestrogen resistance in breast cancer cell lines. FASEB J.
21:4013–4027. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen L, Li Q, She T, Li H, Yue Y, Gao S,
Yan T, Liu S, Ma J and Wang Y: IRE1α-XBP1 signaling pathway, a
potential therapeutic target in multiple myeloma. Leuk Res.
49:7–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ojha R and Amaravadi RK: Targeting the
unfolded protein response in cancer. Pharmacol Res. 120:258–266.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Zhang X, Liang Y, Yu H, Chen X,
Zheng T, Zheng B, Wang L, Zhao L, Shi C and Zhao S: Targeting X
box-binding protein-1 (XBP1) enhances sensitivity of glioma cells
to oxidative stress. Neuropathol Appl Neurobiol. 37:395–405. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Adachi M, Zhao S, Hareyama M, Koong
AC, Luo D, Rando TA, Imai K and Shinomura Y: Preventing oxidative
stress: A new role for XBP1. Cell Death Differ. 16:847–857. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cubillos-Ruiz JR, Silberman PC, Rutkowski
MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE,
Gupta D, Holcomb K, et al: ER stress sensor XBP1 controls
anti-tumor immunity by disrupting dendritic cell homeostasis. Cell.
161:1527–1538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mohamed E, Cao Y and Rodriguez PC:
Endoplasmic reticulum stress regulates tumor growth and anti-tumor
immunity: A promising opportunity for cancer immunotherapy. Cancer
Immunol Immunother. 66:1069–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blais JD, Addison CL, Edge R, Falls T,
Zhao H, Wary K, Koumenis C, Harding HP, Ron D, Holcik M and Bell
JC: Perk-dependent translational regulation promotes tumor cell
adaptation and angiogenesis in response to hypoxic stress. Mol Cell
Biol. 26:9517–9532. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de la Cadena SG, Hernandez-Fonseca K,
Camacho-Arroyo I and Massieu L: Glucose deprivation induces
reticulum stress by the PERK pathway and caspase-7- and
calpain-mediated caspase-12 activation. Apoptosis. 19:414–427.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rouschop KM, Dubois LJ, Keulers TG, van
den Beucken T, Lambin P, Bussink J, van der Kogel AJ, Koritzinsky M
and Wouters BG: PERK/eIF2α signaling protects therapy resistant
hypoxic cells through induction of glutathione synthesis and
protection against ROS. Proc Natl Acad Sci USA. 110:4622–4627.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schewe DM and Aguirre-Ghiso JA:
ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor
cells in vivo. Proc Natl Acad Sci USA. 105:10519–10524. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsuzawa A, Nishitoh H, Tobiume K, Takeda
K and Ichijo H: Physiological roles of ASK1-mediated signal
transduction in oxidative stress- and endoplasmic reticulum
stress-induced apoptosis: Advanced findings from ASK1 knockout
mice. Antioxid Redox Signal. 4:415–425. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen TH, Chiang YH, Hou JN, Cheng CC,
Sofiyatun E, Chiu CH and Chen WJ: XBP1-mediated BiP/GRP78
upregulation copes with oxidative stress in mosquito cells during
dengue 2 virus infection. Biomed Res Int. 2017:35191582017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin D, Li Y, Yang J, Wang G, Margariti
A, Jiang Z, Yu H, Zampetaki A, Hu Y, Xu Q and Zeng L: Unspliced
X-box-binding protein 1 (XBP1) protects endothelial cells from
oxidative stress through interaction with histone deacetylase 3. J
Biol Chem. 289:30625–30634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matés JM, Pérez-Gómez C and Núñez de
Castro I: Antioxidant enzymes and human diseases. Clin Biochem.
32:595–603. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cuadrado A and Nebreda AR: Mechanisms and
functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cuenda A and Rousseau S: p38 MAP-kinases
pathway regulation, function and role in human diseases. Biochim
Biophys Acta. 1773:1358–1375. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Engelberg D: Stress-activated protein
kinases-tumor suppressors or tumor initiators. Semin Cancer Biol.
14:271–282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grossi V, Peserico A, Tezil T and Simone
C: p38α MAPK pathway: A key factor in colorectal cancer therapy and
chemoresistance. World J Gastroenterol. 20:9744–9758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
